Developer of biosynthesis and green chemical technology intended for biomedicine. The company develops biomedicine in a sustainable way that replaces traditional chemical production processes with biosynthesis and green chemical technology, greatly accelerating green manufacturing and improving production efficiency by reducing the use of flammable, explosive and toxic drugs and the emissions of chemical wastes.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
1. Early Stage VC | 30-Jun-2018 | Completed | Generating Revenue |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Fan Peng | Chief Executive Officer & Founder |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
East Lake Venture Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
Wuhan Optics Valley Elite Investment Management | Venture Capital | Minority | 000 0000 | 000000 0 |